Ries Kranse

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registry.

Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registry.

Journal: Journal of clinical epidemiology

Published: January 25, 2022

Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam.

Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam.

Journal: European urology

Published: April 25, 2014

Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.

Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 24, 2014

A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality.

A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality.

Journal: European urology

Published: October 24, 2013

Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.

Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.

Journal: The Canadian journal of urology

Published: June 21, 2013

Fertility potential in a cohort of 65 men with previously acquired undescended testes.

Fertility potential in a cohort of 65 men with previously acquired undescended testes.

Journal: Journal of pediatric surgery

Published: June 13, 2013

Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.

Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.

Journal: European urology

Published: June 07, 2013

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

Journal: European urology

Published: March 11, 2013

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.

Journal: Journal of medical screening

Published: March 01, 2013

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.

Journal: Journal of medical screening

Published: February 08, 2013

Excess all-cause mortality in the evaluation of a screening trial to account for selective participation.

Excess all-cause mortality in the evaluation of a screening trial to account for selective participation.

Journal: Journal of medical screening

Published: February 08, 2013

The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.

The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.

Journal: Diseases of the colon and rectum

Published: April 20, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026